HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Scott McKenzie Selected Research

Epoetin Alfa (Epogen)

9/2007Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.
7/2007Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in anemic predialysis chronic kidney disease patients from an observational study.
10/2006Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studies.
9/2006Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations.
5/2006Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia.
1/2006Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.
1/2006Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations.
9/2005Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Scott McKenzie Research Topics

Disease

9Anemia
10/2012 - 09/2005
9Neoplasms (Cancer)
09/2012 - 09/2005
4Chronic Renal Insufficiency
09/2012 - 01/2006
2Prostatic Neoplasms (Prostate Cancer)
05/2014 - 07/2013
1Crohn Disease (Crohn's Disease)
01/2012
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2012
1Ulcerative Colitis
01/2012
1Rheumatoid Arthritis
07/2010
1Arthralgia (Joint Pain)
07/2010

Drug/Important Bio-Agent (IBA)

8Darbepoetin alfa (Aranesp)FDA Link
09/2007 - 09/2005
8Epoetin Alfa (Epogen)FDA Link
09/2007 - 09/2005
5HematinicsIBA
09/2012 - 03/2009
2Infliximab (Remicade)FDA Link
01/2012 - 07/2010
1Abiraterone AcetateIBA
05/2014
1Prednisone (Sone)FDA LinkGeneric
05/2014
1Estrogens (Estrogen)FDA Link
07/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2013
1AndrogensIBA
07/2013
1Androgen Antagonists (Antiandrogens)IBA
07/2013
1Hemoglobins (Hemoglobin)IBA
10/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
09/2012
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
09/2012
1IronIBA
09/2012
1Etanercept (Enbrel)FDA Link
07/2010
1Adalimumab (Humira)FDA Link
07/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010
1Pharmaceutical PreparationsIBA
10/2006

Therapy/Procedure

9Drug Therapy (Chemotherapy)
07/2013 - 09/2005
4Therapeutics
07/2013 - 07/2010
2Castration
05/2014 - 07/2013
2Long-Term Care
10/2012 - 09/2012
1Activities of Daily Living (ADL)
10/2012